Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro

European Neuropsychopharmacology

Volumn 19, Issue 10, 2009, Pages 726-734

  Amit, Ben Hayman ^a,b   Gil Ad, Irit ^a,b   Taler, Michal ^a   Bar, Meytal ^a,b   Zolokov, Amichai ^a,b   Weizman, Abraham ^a,b,c  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Antidepressants; Chemosensitizers; Jurkat; Sertraline; T cell leukemia; T cell lymphoma

Indexed keywords

CASPASE 3; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOXETINE; METHYLPREDNISOLONE; MITOGEN ACTIVATED PROTEIN KINASE; PAROXETINE; PROTEIN BCL 2; SERTRALINE; STRESS ACTIVATED PROTEIN KINASE; VERAPAMIL; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR CELL DESTRUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTHERAPY, ADJUVANT; DOXORUBICIN; DRUG INTERACTIONS; HUMANS; JURKAT CELLS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MITOGEN-ACTIVATED PROTEIN KINASES; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; VINCRISTINE;

EID: 69049117142     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.06.003     Document Type: Article

References (44)

1. Abbaszadegan M.R., Foley N.E., Gleason-Guzman M.C., and Dalton W.S. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line. Int. J. Cancer 66 (1996) 506-514
2. Abdul M., Logothet C.J., and Hoosein N.M. Growth inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines. J. Urol. 154 (1995) 247-250
3. Ahmed S.A., Gogal R.M., and Walsh J.E. A new rapid and simple non-radioactive assay to monitor and determine proliferation of lymphocytes: an alternative to {3H} thymidine incorporation assay. J. Immunol. Methods 170 (1994) 211-224
4. Bahl S., Cotterchio M., Kreiger N., and Klar N. Antidepressant medication use and non-Hodgkin's lymphoma risk: no association. Am. J. Epidemiol. 160 (2004) 566-575
5. Barbey J.T., and Roose S.P. SSRI safety in overdose. J. Clin. Psychiatry 59 Suppl. 15 (1998) 42-48
6. Barkan T., Gurwitz D., Levy G.T., Weizman A., and Rehavi M. Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes. Eur. Psychopharmacol. 14 (2004) 237-243
7. Carson H.J., Zweigart M., and Lueck N.E. Death from asthma associated with sertraline overdose. Am. J. Forensic Med. Pathol. 21 (2000) 273-275
8. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50 4 (2001) 260-265
9. Davies T.S., and Klowe W.M. Preclinical toxicological evaluation of sertraline hydrochloride. Drug Chem. Toxicol. 21 (1998) 163-179
10. Diamond M., Kelly J.P., and Connor T.J. Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur. Neuropsychopharmacol. 16 (2006) 481-490
11. Doogan D.P., and Caillard V. Sertraline: a new antidepressant. J. Clin. Psychiatry 49 Suppl (1988) 46-51
12. Duan W., Peng Q., Masuda N., Ford E., Tryggestad E., Ladenheim B., Zhao M., Cadet J.L., Wong J., and Ross C.A. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol. Dis. 30 3 (2008) 312-322
13. ++ binding protein (S100)-dependent apoptosis in rat phaeochromocytoma cells. Exp. Physiol. 85 (2000) 243-253
14. Gil-Ad I., Zolokov A., Lomnitski L., Taler M., Bar M., Luria D., Ram E., and Weizman A. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int. J. Oncol. 33 (2008) 277-286
15. Goeringer K.E., Raymon L., Christian G.D., and Logan B.K. Postmortem forensic toxicology of selective serotonin reuptake inhibitors: a review of pharmacology and report of 168 cases. J. Forensic Sci. 45 (2000) 633-648
16. Goodell M., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1;183 4 (1996) 1797-1806
17. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., and Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275 51 (2000) 40096-40105
18. Hyman S.E., Arana G.W., and Rosenbaum J.F. Handbook of Psychiatric Drug Therapy. 3rd edition (1996), Little & Brown, Boston
19. Jannuzzi G., Gatti G., Magni P., Spina E., Pacifici R., Zuccaro P., Torta R., Guarneri L., and Perucca E. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response. Ther. Drug Monit. 24 (2002) 616-627
20. Koch J.M., Kell S., and Aldenhoff J.B. Differential effects of fluoxetine and imipramine on the phosphorylation of the transcription factor CREB and cell-viability. J. Psychiatry Res. 37 (2003) 53-59
21. Levkovitz Y., Gil-Ad I., Zeldich E., Dayag M., and Weizman A. Differential induction of apoptosis by antidepressants in glioma and neuroblastoma cell lines: evidence for p-c-Jun, cytochrome c, and caspase-3 involvement. J. Mol. Neurosci. 27 (2005) 29-42
22. Martel J., Payet M.D., and Dupuis G. The MDR1 (P-glycoprotein) and MRP (P-190) transporters do not play a major role in the intrinsic multiple drug resistance of Jurkat T lymphocytes. Leuk. Res. 21 (1997) 1077-1086
23. Mercier G., Lennon A.M., Renouf B., Dessouroux A., Ramaugé M., Courtin F., and Pierre M. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 24 2 (2004) 207-216
24. Mostert J.P., Admiraal-Behloul F., Hoogduin J.M., Luyendijk J., Heersema D.J., Van Buchem M.A., and De Keyser J. Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study. J. Neurol. Neurosurg. Psychiatry 79 (2008) 1027-1031
25. Nociari M.M., Shalev A., Benias P., and Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods 15 (1998) 157-167
26. Peer D., Dekel Y., Melikhov D., and Margalit R. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Cancer res. 64 (2004) 7562-7569
27. Pellegrino T.C., and Bayer B.M. Modulations of immune cell function following fluoxetine administration in rats. Pharmacol. Biochem. Behav. 59 (1998) 151-157
28. Pennock G.D., Dalton W.S., Roeske W.R., Appleton C.P., Mosley K., Plezia P., Miller T.P., and Salmon S.E. Systemic toxic effects associated with high dose verapamil infusion and chemotherapy administration. J. Natl. Cancer. Inst. 83 (1991) 105-110
29. Roumestan C., Michel A., Bichon F., Portet K., Detoc M., Henriquet C., Jaffuel D., and Mathieu M. Anti-inflammatory properties of desipramine and fluoxetine. Respir. Res. 8 (2007) 35
30. Sadock B.J., and Sadock V.A. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 7th edition vol. 2 (2000), Lippincott Williams & Wilkins, Baltimore 2435-2451
31. Salmon S.E., Dalton W.S., Grogan T.M., Plezia P., Lehnert M., Roe D.J., and Miller T.P. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer. Blood 78 (1991) 44-50
32. Schuster C., Fernbach N., Rix U., Superti-Furga G., Holy M., Freissmuth M., Sitte H.H., and Sexl V. Selective serotonin reuptake inhibitors-a new modality for the treatment of lymphoma/leukaemia?. Biochem. Pharmacol. 74 (2007) 1424-1435
33. Serafeim A., Holder M.J., Grafton G., and Chamba A. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood 101 (2003) 3212-3219
34. Spanova A., Kovaru H., Lisa V., Lukasova E., and Rittich B. Estimation of apoptosis in C6 glioma cells treated with antidepressants. Physiol. Res. 46 (1997) 161-164
35. Srtober W. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. (2001) Appendix 3B
36. Taler M., Gil-Ad I., Lomnitski L., Korov I., Baharav E., Bar M., Zolokov A., and Weizman A. Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur. Neuropsychopharmacol. 17 (2007) 774-780
37. Tramontina A.C., Tramontina F., Bobermin L.D., Zanotto C., Souza D.F., Leite M.C., Nardin P., Gottfried C., and Gonçalves C.A. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 6 (2008) 1580-1583
38. Tsao C.W., Lin Y.S., Chen C.C., Bai C.H., and Wu S.R. Cytokines and serotonin transporter in patients with major depression. Prog Neuropsychopharmacol. Biol. Psychiatry. 30 (2006) 899-905
39. Van Eldik L.J., Christie-Pope B., Bolin L.M., Shooter E.M., and Whetseel Jr. W.O. Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 542 (1991) 280-285
40. Wang S., Rosengren L.E., Franlund M., Hamberger A., and Haglid K.G. Bcl-2 expression regulates cell sensitivity to S100β-mediated apoptosis. Mol. Brain. Res. 70 (1999) 167-176
41. Whitaker-Azmitia P.M., Murphy R., and Azmitia E.C. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 528 (1990) 155-159
42. Winek C.L., Wahba W.W., Winek Jr. C.L., and Blzer T.W. Drug and chemical blood-level data 2001. Forensic Sci. Int. 122 (2001) 107-123
43. Xu W., Tamim H., Shapiro S., Stang M.R., and Collet J.P. Use of antidepressants and risk of colorectal cancer: a nested case-control study. Lancet Oncol. 7 (2006) 301-308
44. Zusso M., Debetto P., Guidolin D., Barbierato M., Manev H., and Giusti P. Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum. Biochem. Pharmacol. 76 (2008) 391-403